Institutional

As part of the renewal of its research unit, which takes place every 5 years, the Brain Institute received last week the members of the Scientific Advisory Board (SAB). This is a first decisive step in this strategic evaluation for the Institute.

It is with deep sadness that we inform you of the death of our colleague and friend, Prof. Charles Duyckaerts, who left us on the evening of Saturday, August 6, after several years of battling illness.

In 2021, the Institute’s teams were at the origin of important scientific breakthroughs, with the indispensable support of the technological platforms, whose restructuring has made it possible to meet everyone’s needs as well as possible.

The Institut du Cerveau – Paris Brain Institute is an internationally renowned neuroscience research institute located in Paris, France, on the campus of the Pitié-Salpêtrière hospital, providing world class expertise in basic and clinical...

The Richard Lounsbery Prize 2022, awarded by the French Academy of Sciences and the American National Academy of Sciences (NAS), has been awarded to Claire Wyart (Inserm), head of the "Spinal Sensory Signaling" team at the Pris Brain Institute, for...

Paris Brain Institute announces a new research collaboration with Pfizer Inc. aimed at advancing the understanding of rare neurodegenerative diseases

Prof. Catherine Lubetzki, winner of the Prize Pasteur-Weizmann / Servier 2021 for her work on myelin regeneration in the treatment of multiple sclerosis

The Institut du Cerveau - Paris Brain Institute is an internationally renowned neuroscience research institute located in Paris, France, on the campus of the Pitié-Salpêtrière hospital, providing world class expertise in basic and clinical...

The objective of the new scientific domain ( Computational modelling in neuroscience) is to recognise the particular interdisciplinary experience of some researchers at Paris Brain Institute. Up to now people using a computational neuroscience...

By signing this declaration, the Paris Brain Institute is now part of network of more than 150 scientific organisations committed to more diversity and equity in the scientific world.

Top research institutes from Germany, France, Belgium and the UK have formed a new alliance to combat neurodegenerative diseases. Their mission? Catalysing a United Response in Europe to Neurodegenerative Diseases, or CURE-ND for short.